TP53 and cancer: Therefore, selenium polymer nanocarriers were recently developed to induce cell cycle arrest and p53-mediated caspase-independent apoptosis in order to arrest cancer cell proliferation, which could reduce the cytotoxicity of many chemotherapeutic drugs, including DOX [130].